Ca2+ signalling checkpoints in cancer:: remodelling Ca2+ for cancer cell proliferation and survival

被引:604
作者
Roderick, H. Llewelyn [1 ,2 ]
Cook, Simon J. [2 ]
机构
[1] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England
[2] Babraham Inst, Mol Signalling Lab, Cambridge CB22 3AT, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1038/nrc2374
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Increases in cytosolic free Ca2+ ([Ca2+](i)) represent a ubiquitous signalling mechanism that controls a variety of cellular processes, including proliferation, metabolism and gene transcription, yet under certain conditions increases in intracellular Ca2+ are cytotoxic. Thus, in using Ca2+ as a messenger, cells walk a tightrope in which [Ca2+](i) is strictly maintained within defined boundaries. To adhere to these boundaries and to sustain their modified phenotype, many cancer cells remodel the expression or activity of their Ca2+ signalling apparatus. Here, we review the role of Ca2+ in promoting cell proliferation and cell death, how these processes are remodelled in cancer and the opportunities this might provide for therapeutic intervention.
引用
收藏
页码:361 / 375
页数:15
相关论文
共 218 条
[1]   A key role for TRPM7 channels in anoxic neuronal death [J].
Aarts, M ;
Iihara, K ;
Wei, WL ;
Xiong, ZG ;
Arundine, M ;
Cerwinski, W ;
MacDonald, JF ;
Tymianski, M .
CELL, 2003, 115 (07) :863-877
[2]   The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease [J].
Abel, M ;
Hoenderop, J ;
Bindels, R .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 (04) :295-306
[3]   Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin [J].
Agell, N ;
Bachs, O ;
Rocamora, N ;
Villalonga, P .
CELLULAR SIGNALLING, 2002, 14 (08) :649-654
[4]   TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS [J].
ALBANESE, C ;
JOHNSON, J ;
WATANABE, G ;
EKLUND, N ;
VU, D ;
ARNOLD, A ;
PESTELL, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23589-23597
[5]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[6]   Mechanism of activation and function of protein kinase B [J].
Alessi, DR ;
Cohen, P .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) :55-62
[7]   Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis [J].
Assefa, Z ;
Bultynck, G ;
Szlufcik, K ;
Kasri, NN ;
Vermassen, E ;
Goris, J ;
Missiaen, L ;
Callewaert, G ;
Parys, JB ;
De Smedt, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (41) :43227-43236
[9]   Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells [J].
Balmanno, K ;
Cook, SJ .
ONCOGENE, 1999, 18 (20) :3085-3097
[10]   p53: new roles in metabolism [J].
Bensaad, Karim ;
Vousden, Karen H. .
TRENDS IN CELL BIOLOGY, 2007, 17 (06) :286-291